A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: Anne W Lucky, William Koltun, Diane Thiboutot, Minoo Niknian, Carole Sampson-Landers, Paul Korner, Joachim Marr
Institutions: Pennsylvania State University, Bayer (Germany)
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2264027203
